Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc.（KPRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · KPRX · 截至 2026年6月9日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Kiora Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
KPRX 季度内部人买卖趋势
KPRX 内幕交易卖出 · KPRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · KPRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
KPRX 高管卖出股份 · KPRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 1, 2026 | Tosca Melissa CFO | Other | 929 | $2K | Form 4 |
| Apr 1, 2026 | Daniels Eric Joseph Chief Development Officer | Other | 929 | $2K | Form 4 |
| Apr 1, 2026 | Strem Brian M. President and CEO · Director | Other | 1,906 | $4K | Form 4 |
| Mar 6, 2026 | Daniels Eric Joseph Chief Development Officer | Award | 6,533 | — | Form 4 |
| Mar 6, 2026 | Strem Brian M. President and CEO · Director | Award | 16,733 | — | Form 4 |
| Mar 6, 2026 | Tosca Melissa CFO | Award | 6,533 | — | Form 4 |
| Mar 3, 2026 | Daniels Eric Joseph Chief Development Officer | Other | 238 | $481 | Form 4 |
| Mar 3, 2026 | Strem Brian M. President and CEO · Director | Other | 238 | $481 | Form 4 |
| Apr 1, 2025 | Tosca Melissa CFO | Award | 7,772 | — | Form 4 |
| Apr 1, 2025 | Daniels Eric Joseph Chief Development Officer | Award | 7,772 | — | Form 4 |
| Apr 1, 2025 | Strem Brian M. President and CEO · Director | Award | 15,941 | — | Form 4 |
| Sep 11, 2024 | Stengone Carmine N. Director | Purchase | 1,250 | $5K | Form 4 |
| Sep 10, 2024 | Shapiro Aron Director | Purchase | 3,000 | $11K | Form 4 |
| Aug 19, 2024 | Walters-Hoffert Lisa Director | Purchase | 1,250 | $5K | Form 4 |
| Aug 19, 2024 | TYLE PRAVEEN Director | Purchase | 5,000 | $20K | Form 4 |
| Aug 14, 2024 | Tosca Melissa CFO | Purchase | 2,000 | $6K | Form 4 |
| Jul 1, 2024 | Strem Brian M. President and CEO · Director | Award | 15,629 | — | Form 4 |
| Jul 1, 2024 | Tosca Melissa CFO | Award | 7,620 | — | Form 4 |
| Jul 1, 2024 | Daniels Eric Joseph Chief Development Officer | Award | 7,355 | — | Form 4 |
| Jun 14, 2024 | Tosca Melissa EVP Finance | Purchase | 100 | $525 | Form 4 |
| Jun 14, 2024 | Daniels Eric Joseph Chief Development Officer | Purchase | 1,431 | $8K | Form 4 |
| Jun 13, 2024 | Parsons Erin Director | Purchase | 5,260 | $26K | Form 4 |
| Jun 13, 2024 | Strem Brian M. President and CEO · Director | Purchase | 3,000 | $15K | Form 4 |
| Sep 29, 2023 | Tosca Melissa EVP Finance | Award | 30,000 | — | Form 4 |
| Sep 29, 2023 | Daniels Eric Joseph Chief Development Officer | Award | 62,500 | — | Form 4 |
Daniels Eric Joseph
Chief Development Officer
日期
Jun 14
股数
1,431
均价
$5.29
总金额
$8K
Strem Brian M.
President and CEO · Director
日期
Jun 13
股数
3,000
均价
$5.00
总金额
$15K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 KPRX 内幕交易
KPRX 内幕交易
Kiora Pharmaceuticals, Inc.（KPRX）内幕交易数据来源于公司内部人（包括Daniels Eric Joseph (Chief Development Officer), Strem Brian M. (President and CEO · Director), Tosca Melissa (CFO)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。KPRX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Kiora Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
KPRX 内幕交易 · 5个问题Kiora Pharmaceuticals, Inc.（KPRX）的内部人包括高管和董事，如Daniels Eric Joseph (Chief Development Officer), Strem Brian M. (President and CEO · Director), Tosca Melissa (CFO)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026